Folgen
Rajal B. Shah
Rajal B. Shah
Dr. Charles T. Ashworth Professor of Pathology, University of Texas Southwestern Medical Center
Bestätigte E-Mail-Adresse bei utsouthwestern.edu
Titel
Zitiert von
Zitiert von
Jahr
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins, DR Rhodes, S Perner, SM Dhanasekaran, R Mehra, XW Sun, ...
science 310 (5748), 644-648, 2005
47952005
Delineation of prognostic biomarkers in prostate cancer
SM Dhanasekaran, TR Barrette, D Ghosh, R Shah, S Varambally, ...
Nature 412 (6849), 822-826, 2001
21482001
Integrative molecular concept modeling of prostate cancer progression
SA Tomlins, R Mehra, DR Rhodes, X Cao, L Wang, SM Dhanasekaran, ...
Nature genetics 39 (1), 41-51, 2007
10912007
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
SA Tomlins, B Laxman, SM Dhanasekaran, BE Helgeson, X Cao, ...
Nature 448 (7153), 595-599, 2007
10022007
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression
S Varambally, J Yu, B Laxman, DR Rhodes, R Mehra, SA Tomlins, ...
Cancer cell 8 (5), 393-406, 2005
8892005
Role of the TMPRSS2-ERG gene fusion in prostate cancer
SA Tomlins, B Laxman, S Varambally, X Cao, J Yu, BE Helgeson, Q Cao, ...
Neoplasia 10 (2), 177-IN9, 2008
8802008
Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition
S Shangary, D Qin, D McEachern, M Liu, RS Miller, S Qiu, ...
Proceedings of the National Academy of Sciences 105 (10), 3933-3938, 2008
8132008
Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program
RB Shah, R Mehra, AM Chinnaiyan, R Shen, D Ghosh, M Zhou, ...
Cancer research 64 (24), 9209-9216, 2004
7272004
TMPRSS2: ETV4 gene fusions define a third molecular subtype of prostate cancer
SA Tomlins, R Mehra, DR Rhodes, LR Smith, D Roulston, BE Helgeson, ...
Cancer research 66 (7), 3396-3400, 2006
5842006
Prostate-specific membrane antigen expression as a predictor of prostate cancer progression
S Perner, MD Hofer, R Kim, RB Shah, H Li, P Möller, RE Hautmann, ...
Human pathology 38 (5), 696-701, 2007
5562007
A polycomb repression signature in metastatic prostate cancer predicts cancer outcome
J Yu, J Yu, DR Rhodes, SA Tomlins, X Cao, G Chen, R Mehra, X Wang, ...
Cancer research 67 (22), 10657-10663, 2007
4072007
The role of SPINK1 in ETS rearrangement-negative prostate cancers
SA Tomlins, DR Rhodes, J Yu, S Varambally, R Mehra, S Perner, ...
Cancer cell 13 (6), 519-528, 2008
4012008
Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer
R Mehra, SA Tomlins, R Shen, O Nadeem, L Wang, JT Wei, KJ Pienta, ...
Modern Pathology 20 (5), 538-544, 2007
3782007
Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer
R Mehra, SA Tomlins, J Yu, X Cao, L Wang, A Menon, MA Rubin, ...
Cancer research 68 (10), 3584-3590, 2008
3322008
Noninvasive detection of TMPRSS2: ERG fusion transcripts in the urine of men with prostate cancer
B Laxman, SA Tomlins, R Mehra, DS Morris, L Wang, BE Helgeson, ...
Neoplasia 8 (10), 885-888, 2006
3212006
Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity
S Gobbo, JN Eble, DJ Grignon, G Martignoni, GT MacLennan, RB Shah, ...
The American journal of surgical pathology 32 (8), 1239-1245, 2008
3142008
Comparison of the basal cell-specific markers, 34βE12 and p63, in the diagnosis of prostate cancer
RB Shah, M Zhou, M LeBlanc, M Snyder, MA Rubin
The American journal of surgical pathology 26 (9), 1161-1168, 2002
3082002
Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States
JM Mosquera, R Mehra, MM Regan, S Perner, EM Genega, G Bueti, ...
Clinical cancer research 15 (14), 4706-4711, 2009
2852009
Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications
JM Mosquera, S Perner, EM Genega, M Sanda, MD Hofer, KD Mertz, ...
Clinical Cancer Research 14 (11), 3380-3385, 2008
2792008
Integrative genomics analysis reveals silencing of β-adrenergic signaling by polycomb in prostate cancer
J Yu, Q Cao, R Mehra, B Laxman, J Yu, SA Tomlins, CJ Creighton, ...
Cancer cell 12 (5), 419-431, 2007
2712007
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20